Induction of hypoxia following radiofrequency ablation of liver tumors.

Induction of hypoxia following radiofrequency ablation of liver tumors. - Radiofrequency ablation and hypoxia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36653

Enrollment

Registered

2010-11-24

Start date

2012-04-18

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer liver tumor

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: *Patients with liver tumor(s) treated with percutaneous RFA *Age > 18 years *Written informed consent

Exclusion criteria

Exclusion criteria: *Open RFA procedure for liver tumor by the surgeon *Claustrophobia prohibiting PET-scanning

Design outcomes

Primary

Measure	Time frame
Primary outcome measure: The endpoint of this study is the presence (or absence) of hypoxia (defined as demonstrable FAZA uptake) in the necrotic rim induced by RFA.	—

Countries

Netherlands

Outcome results